Novartis reported CHF13.29B in Sales Revenues for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Abbvie ABBV:US $ 13959M 949M
Alcon AG ALC:SW 2.11B 180M
Amgen AMGN:US $ 6526M 625M
AstraZeneca AZN:LN 8220M 900M
Bayer BAYN:GR € 10854M 1474M
Biogen BIIB:US $ 2775M 81M
Bristol Myers Squibb BMY:US $ 11703M 630M
Eli Lilly And LLY:US $ 6740.1M 65.5M
Fresenius FRE:GR € 9246M 262M
Fresenius Medical Care FME:GR € 4320M 110M
Galapagos GLPG:NA € 153.07M 28.91M
Genmab GEN:DC DK 1972M 391M
Gilead Sciences GILD:US $ 6217M 206M
GlaxoSmithKline GSK:LN 8092M 674M
GRIFOLS GRF:SM € 1351.9M 167.16M
H. Lundbeck A/S LUN:DC 3.96B 313M
Hikma Pharmaceutical HIK:LN 1.22B 7M
Johnson & Johnson JNJ:US $ 23312M 991M
Lonza Group LONN:SW 2.54B 1.11B
Merck MRK:GR € 4870M 239M
Merk MRK:US $ 11402M 678M
Novartis NOVN:VX SF 13294M 600M
Novartis NVS:US $ 13294M 600M
Orion ORNBV:FH € 254.9M 13.8M
Pfizer PFE:US $ 18977M 4395M
Philips PHIA:NA € 4230M 403M
Recordati REC:IM € 386M 1.16M
Regeneron Pharmaceuticals REGN:US $ 5138.5M 2609.8M